Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...

If the COVID-19 pandemic has done one thing, it’s made us all more familiar with some of the important players in the immune system. Antibodies, B cells, and T cells are among the best known parts of ...

"It's of course very aggressive -- but it is possible," a scientist says. With top White House officials indicating a coronavirus vaccine may be available by January 2021, scientists and vaccine ...

Coronavirus transmission has been slowly, but steadily, on the rise in recent weeks — and though local public health officials say the most recently available data doesn’t yet indicate a surge akin to ...

The latest COVID-19 boosters were approved last month, but not everyone has been able to get them yet. The updated vaccine doses, which the Food and Drug Administration approved in late August, are ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

It’s late August, there’s a hurricane coming up the East Coast, schools are starting to open, and no one has any idea who can get an updated Covid-19 shot. The Covid-19 pandemic is over, but the virus ...

SAN FRANCISCO (KGO) -- As the impact of the coronavirus continues to grow across the United States the financial implications also mount. People are losing work as businesses close, and many consumers ...

Jeff M. Smith is a research fellow in The Heritage Foundation's Asian Studies Center, focusing on South Asia. Arguably, however, the commission’s most infuriating conclusion was this: The global ...